Eccentric osteolytic lesion of the proximal tibia secondary to solitary bone plasmacytoma managed with reconstruction surgery: a case report
DOI:
https://doi.org/10.18203/2349-2902.isj20261588Keywords:
Solitary plasmacytoma, Osteolytic lesion, Cementoplasty, Pathological fracture, Orthopaedic oncology, Intralesional curettageAbstract
Solitary bone plasmacytoma (SBP) is a rare plasma cell neoplasm characterized by localized monoclonal proliferation without systemic involvement, most commonly affecting the axial skeleton, while involvement of long bones such as the tibia remains distinctly uncommon. We report a case of a 51-year-old male presenting with progressive pain in the right proximal leg and difficulty in weight-bearing for three months. Clinical examination revealed localized tenderness over the medial proximal tibia with restricted knee motion. Radiographs demonstrated a well-defined eccentric osteolytic lesion with cortical breach and pathological fracture, while advanced imaging confirmed an intramedullary lesion with cortical destruction. Histopathological evaluation revealed sheets of malignant plasma cells, confirming plasmacytoma. Comprehensive systemic work-up, including skeletal survey, bone marrow biopsy, and biochemical analysis, excluded multiple myeloma. The patient underwent intralesional curettage followed by polymethylmethacrylate cement augmentation and proximal tibial locking plate fixation to restore structural stability. SBP involving the tibia is uncommon and may mimic other osteolytic lesions, necessitating thorough diagnostic evaluation to exclude systemic disease. Surgical management becomes essential in cases with structural compromise, where cement augmentation provides immediate mechanical stability, facilitates early mobilization, and may contribute to local tumor control. Intralesional curettage combined with cement-augmented internal fixation represents an effective reconstructive strategy for tibial SBP, enabling early weight-bearing and favorable functional outcomes. Long-term surveillance remains essential to monitor for progression to multiple myeloma.
References
Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96(6):2037-44.
Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124(6):717-26.
Caers J, Paiva B, Zamagni E, Leleu X, Bladé J, Kristinsson SY, et al. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations. Haematologica. 2018;103(11):1778-90.
Jawad MU, Scully SP. Skeletal plasmacytoma: progression of disease and impact of local treatment. Cancer. 2009;115(22):5408-17.
Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone: Mayo Clinic experience. Cancer. 1989;63(3):569-74.
Campanacci M. Bone and soft tissue tumors. 2nd ed. Vienna: Springer. 2013.
Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860-73.
Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41(5):1063-7.
Ozsahin M, Tsang RW, Poortmans P, Belkacemi Y, Bolla M, Dinshaw KA, et al. Outcomes and patterns of failure in solitary plasmacytoma. Int J Radiat Oncol Biol Phys. 2006;64(1):210-7.
Knobel D, Zouhair A, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, et al. Prognostic factors in solitary plasmacytoma of bone: a multicenter rare cancer network study. Cancer. 2006;106(5):1021-7.
Dagan R, Morris CG, Kirwan J, Mendenhall WM. Solitary plasmacytoma. Am J Hematol. 2009;84(6):395-8.
Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001;50(1):113-20.
Bolek TW, Marcus RB Jr, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Cancer. 1996;78(2):380-6.
Mendenhall CM, Thar TL, Million RR. Solitary plasmacytoma of bone and soft tissue. Cancer. 1980;45(3):469-74.
Harrington KD. Orthopaedic management of extremity and pelvic lesions. J Bone Joint Surg Am. 1981;63(8):1271-80.
Bataille R, Sany J. Solitary myeloma: clinical and prognostic features. J Clin Oncol. 1991;9(1):83-7.
Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85(11):2305-14.
Weber KL. Surgical management of bone tumors. J Am Acad Orthop Surg. 2002;10(1):10-20.